Research
Monday, December 27th, 2021
![ipatimup - Instituto de Patologia e Imunologia Molecular da Universidade do Porto](https://uromonitor.com/wp-content/uploads/2021/12/logo-ipatimup.png)
The test was developed by researchers from IPATIMUP, a renowned cancer research center (www.ipatimup.pt) at Oporto, Portugal.
Uromonitor’s team of researchers are experts in biomarkers in the cancer biology and molecular genetics field.